Acute flaccid myelitis: long-term outcomes recorded in the CAPTURE study compared with paediatric transverse myelitis

Benjamin Greenberg1, Patricia Plumb1, Gary Cutter2

  • 1Neurology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.

BMJ Neurology Open
|June 3, 2021
PubMed
Abstract

Insights

Acute flaccid myelitis (AFM) and transverse myelitis (TM) share similar treatment responses to corticosteroids. This prospective study identified distinct AFM patterns, informing future therapeutic strategies for pediatric myelitis patients.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Infectious Diseases

Background:

  • The USA has experienced three outbreaks of acute flaccid myelitis (AFM) since 2014.
  • Unique features and treatment responses of AFM have not been prospectively studied.
  • This study aimed to prospectively measure outcomes in pediatric myelitis patients relative to treatments.

Purpose of the Study:

  • To prospectively investigate clinical features and treatment outcomes in pediatric patients with myelitis, including acute flaccid myelitis (AFM) and transverse myelitis (TM).
  • To identify distinct patterns within AFM cases and compare treatment responses between AFM and TM.

Main Methods:

  • A prospective, multicenter, non-randomized, observational cohort study conducted over 5 years with 1-year follow-up.
  • Data collected from pediatric patients diagnosed with myelitis within 6 months of symptom onset in North America.
  • Patients classified as AFM or TM based on clinical and radiographic findings.

Main Results:

  • The study included 90 patients with AFM and TM. Fifty-one AFM patients exhibited two patterns: grey matter restricted or concomitant white matter involvement.
  • Corticosteroid treatment showed similar improvement in deficits for AFM and TM cohorts (p=0.97).
  • Specific AFM patterns may explain motor deficits in patients with cervical spine lesions.

Conclusions:

  • Treatment approaches for AFM should be individualized.
  • Prospective controlled studies are needed to evaluate long-term outcomes in the growing AFM patient population.

Related Concept Videos